FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

713395006: Brentuximab vedotin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3289141012 Brentuximab vedotin (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3289150014 Brentuximab vedotin en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brentuximab vedotin Is a Peptide false Inferred relationship Existential restriction modifier
Brentuximab vedotin Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Brentuximab vedotin Has disposition Microtubule inhibitor true Inferred relationship Existential restriction modifier
Brentuximab vedotin Is a Substance with microtubule inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Brentuximab vedotin Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing brentuximab vedotin Has active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Brentuximab vedotin Has active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Product containing brentuximab vedotin in parenteral dose form (medicinal product form) Has active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Product containing only brentuximab vedotin in parenteral dose form (medicinal product form) Has active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance True Brentuximab vedotin Inferred relationship Existential restriction modifier 1
Brentuximab vedotin 50mg powder for solution for infusion vials Has active ingredient False Brentuximab vedotin Inferred relationship Existential restriction modifier
Brentuximab vedotin 50mg powder for solution for infusion vials 1 vial Has specific active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier
Adcetris 50mg powder for concentrate for solution for infusion vials (Takeda UK Ltd) 1 vial Has specific active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier
Adcetris 50mg powder for concentrate for solution for infusion vials (Takeda UK Ltd) Has specific active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier
Brentuximab vedotin 50mg powder for solution for infusion vials Has specific active ingredient True Brentuximab vedotin Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start